OMERS Administration Corp’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$684K Hold
13,458
﹤0.01% 721
2025
Q4
$397K Hold
13,458
﹤0.01% 743
2025
Q3
$348K Hold
13,458
﹤0.01% 841
2025
Q2
$371K Hold
13,458
﹤0.01% 701
2025
Q1
$382K Hold
13,458
﹤0.01% 808
2024
Q4
$560K Buy
13,458
+2,240
+20% +$107K ﹤0.01% 672
2024
Q3
$750K Hold
11,218
0.01% 568
2024
Q2
$1.33M Buy
+11,218
New +$1.42M 0.01% 469

Other funds holding MRNA

OMERS Administration Corp's MRNA Position: Q1 2026 in Review

OMERS Administration Corp held its Moderna (MRNA) position steady in Q1 2026 at 13,458 shares worth $684K. The position accounts for ﹤0.01% of the portfolio, ranked #721.

OMERS Administration Corp first reported a position in MRNA in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.33M in Q2 2024. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • OMERS Administration Corp held 13,458 shares of Moderna worth $684K as of Q1 2026.
  • OMERS Administration Corp left its Moderna share count unchanged in Q1 2026.
  • Moderna made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #721 holding.
  • OMERS Administration Corp first reported a position in Moderna in Q2 2024 and has held it in 8 quarters since.
  • OMERS Administration Corp's Moderna position peaked at $1.33M in Q2 2024.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.